Loeser, Anne L.
Gao, Lucy http://orcid.org/0000-0001-7825-8173
Bardia, Aditya
Burkard, Mark E.
Kalinsky, Kevin M.
Peppercorn, Jeffrey
Rugo, Hope S.
Carlson, Martha
Cowden, Janice
Glenn, Lesley
Maues, Julia
McGlown, Sheila
Ni, Andy
Padron, Natalia
Lustberg, Maryam
Article History
Received: 1 August 2022
Accepted: 18 September 2022
First Online: 6 October 2022
Declarations
:
: Lucy Gao: Affiliation with Massachusetts General Hospital. Aditya Bardia is a consultant/member of advisory board for Pfizer, Novartis, Genentech, Merck, Radius Health, Immunomedics/Gilead, Sanofi, Daiichi Pharma/Astra Zeneca, Phillips, Eli Lilly, and Foundation Medicine and receives contracted Research/Grant (to institution) from Genentech, Novartis, Pfizer, Merck, Sanofi, Radius Health, Immunomedics/Gilead, Daiichi Pharma/Astra Zeneca, and Eli Lilly. Mark E. Burkard is a member of Medical advisory board of Strata Oncology and receives research funding from Abbvie, Arcus, Apollomics, Elevation Oncology, Genentech, Loxo Oncology/Lilly, Puma, and Seagen. Kevin M. Kalinsky reports grants/contracts to his institution from Incyte, Novartis, Genentch, Eli Lilly, Pfizer, Calithera, Immunomedics, Acetylon, Seattle Genetics, Amgen, Zentalis, and CytomX Therapeutics; consulting fees/consultant honorarium from Daiichi Sankyo, Eli Lilly, Pfizer, Novartis, Eisai, AstraZeneca, Immunomedics, Merck, Seattle Genetics, Cyclocel, Oncosec, and 4D Pharma; speakers bureau: Eli Lilly; support for attending meetings and/or travel from Eli Lilly, AstraZeneca, and Pfizer; participation on advisory board (steering committee): Immunomedics, AstraZeneca, Ambryx, and Genentech; and stock options/employment: Grail (spouse), Array BioPharma (spouse), and Pfizer (spouse). Jeffrey Peppercorn reports spouse employment: GSK, Research funding Outcomes4me Inc—to institution, consulting Abbott Labs. Hope S. Rugo receives research support for clinical trials through the University of California: Pfizer, Merck, Novartis, Lilly, Roche, Daiichi, Seattle Genetics, Macrogenics, Sermonix, Boehringer Ingelheim, Polyphor, AstraZeneca, Ayala, Astellas, and Gilead; Honoraria from: Puma, Samsung, Mylan, Chugai, Blueprint, and NAPO; and Travel: GE Healthcare. Martha Carlson receives grant funding from Pfizer/NCCN and serves on a patient panel review for AstraZeneca. Maryam Lustberg is a consultant/member of advisory board for Pfizer, Lily, Astra Zeneca, Sanofi, and Novartis.
: This is an observational study. An Institutional Review Board exemption was obtained from Solutions IRB.